Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor

被引:197
|
作者
McFarland-Mancini, Molly M. [1 ]
Funk, Holly M. [1 ]
Paluch, Andrew M. [1 ]
Zhou, Mingfu [1 ]
Giridhar, Premkumar Vummidi [1 ]
Mercer, Carol A. [2 ]
Kozma, Sara C. [1 ]
Drew, Angela F. [1 ]
机构
[1] Univ Cincinnati, Dept Canc & Cell Biol, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA
[2] PDS Biotechnol, Lawrenceburg, IN 47025 USA
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷 / 12期
关键词
CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; ACUTE-PHASE RESPONSE; BREAST-CANCER CELLS; INTERLEUKIN-6; RECEPTOR; ACUTE-INFLAMMATION; PROTEIN-KINASE; IN-VIVO; CYTOKINE RECEPTORS; SIGNAL TRANSDUCER;
D O I
10.4049/jimmunol.0901929
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-6 modulates immune responses and is essential for timely wound healing. As the functions mediated by IL-6 require binding to its specific receptor, IL-6R alpha, it was expected that mice lacking IL-6R alpha would have the same phenotype as IL-6-deficient mice. However, although IL-6R alpha-deficient mice share many of the inflammatory deficits seen in IL-6-deficient mice, they do not display the delay in wound healing. Surprisingly, mice with a combined deficit of IL-6 and IL-6R alpha, or IL-6-deficient mice treated with an IL-6R alpha-blocking Ab, showed improved wound healing relative to mice with IL-6 deficiency, indicating that the absence of the receptor contributed to the restoration of timely wound healing, rather than promiscuity of IL-6 with an alternate receptor. Wounds in mice lacking IL-6 showed delays in macrophage infiltration, fibrin clearance, and wound contraction that were not seen in mice lacking IL-6R alpha alone and were greatly reduced in mice with a combined deficit of IL-6 and IL-6R alpha. MAPK activation-loop phosphorylation was elevated in wounds of IL-6R alpha-deficient mice, and treatment of wounds in these mice with the MEK inhibitor U0126 resulted in a delay in wound healing suggesting that aberrant ERK activation may contribute to improved healing. These findings underscore a deeper complexity for IL-6R alpha function in inflammation than has been recognized previously. The Journal of Immunology, 2010, 184: 7219-7228.
引用
收藏
页码:7219 / 7228
页数:10
相关论文
共 50 条
  • [41] Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response
    Hope, JC
    Campbell, F
    Hopkins, SJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (01) : 197 - 203
  • [42] Overexpression of IL-6 causes osteoporosis and ossification defects in IL-6 transgenic mice.
    De Benedetti, F
    Funari, A
    Muratori, F
    Berni, S
    Ballanti, P
    D'Urbano, LE
    Di Giacinto, C
    Paro, R
    Spica, E
    Ricci, N
    Teti, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S265 - S265
  • [43] IL-6 receptor independent stimulation of human gp130 by viral IL-6
    Müllberg, J
    Geib, T
    Jostock, T
    Hoischen, SH
    Vollmer, P
    Voltz, N
    Heinz, D
    Galle, PR
    Klouche, M
    Rose-John, S
    JOURNAL OF IMMUNOLOGY, 2000, 164 (09): : 4672 - 4677
  • [44] The role of soluble IL-6 receptor in mediating the effects of IL-6 on collagenolytic activity.
    Irwin, CR
    Myrillas, TT
    Traynor, P
    Leadbetter, N
    Cawston, T
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A124 - A124
  • [45] Chimeric molecule IL-6/soluble IL-6 receptor is a potent mitogen for fetal hepatocytes
    Zvibel, I
    Brill, S
    Kariv, R
    Traister, A
    Golan, T
    Chebath, J
    Halpern, Z
    Revel, M
    Oren, R
    JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 200 (02) : 245 - 252
  • [46] IL-6 AND IL-6 RECEPTOR (IL-6R) EXPRESSION AND MODULATION DURING ACUTE-INFLAMMATION IN THE RAT
    GEISTERFER, M
    RICHARDS, C
    BAUMANN, M
    FEY, G
    GWYNNE, D
    GAULDIE, J
    FASEB JOURNAL, 1992, 6 (05): : A1896 - A1896
  • [47] IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor
    Imazeki, I
    Saito, H
    Hasegawa, M
    Shinkura, H
    Kishimoto, T
    Ohsugi, Y
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1998, 20 (07): : 345 - 357
  • [48] Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor
    Zia, Komal
    Nur-e-Alam, Mohammad
    Ahmad, Aftab
    Ul-Haq, Zaheer
    MOLECULAR DIVERSITY, 2024,
  • [49] The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
    Taher, Mustafa Yassin
    Davies, David Marc
    Maher, John
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 1449 - 1462
  • [50] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
    Ali Berkant Avci
    Eugen Feist
    Gerd R. Burmester
    BioDrugs, 2024, 38 : 61 - 71